(Q24246327)

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Prediction of Subclinical Tumor Infiltration in Basal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Episodic progression and regression of basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Human homolog of patched, a candidate gene for the basal cell nevus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

The randomized clinical trial: bias in analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Biology of basal cell carcinoma (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

The anatomical distribution of skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Nonmelanoma cancers of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Multiple nonmelanoma skin cancer in an exposed Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Trends in the presentation and treatment of basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Controversy in Counting and Attributing Events in Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Guidelines for the management of basal cell carcinoma. British Association of Dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

The relationship of sun exposure and solar elastosis to basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

Intralesional interferon therapy for basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

The risk of developing subsequent nonmelanoma skin cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

What causes basal cell carcinoma to be the commonest cancer?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003412.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD003412.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17253489

1 reference

Consolidated OpenCitations Corpus – April 2017